Anne Nunes Anika Therapeutics, Inc. (ANIK) insider trading activity

Anne Nunes is SVP, Chief Operations Officer of Anika Therapeutics, Inc.. Currently has a direct ownership of 16,276 shares of ANIK, which is worth approximately $273,274. The most recent transaction as insider was on Mar 10, 2025, when has been sold 959 shares (Common Stock) at a price of $16.62 per share, resulting in proceeds of $15,938. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 16.3K

20.75% 3M change

46.82% 12M change

Total Value Held $273,274

Anne Nunes Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 10 2025	SELL Payment of exercise price or tax liability	$15,938 $16.62 p/Share	959 Reduced 5.56%	16,276 Common Stock
Mar 10 2025	BUY Exercise of conversion of derivative security	-	3,296 Added 16.05%	17,235 Common Stock
Oct 01 2024	SELL Payment of exercise price or tax liability	$17,765 $24.27 p/Share	732 Reduced 5.15%	13,479 Common Stock
Oct 01 2024	BUY Exercise of conversion of derivative security	-	2,491 Added 14.91%	14,211 Common Stock
Mar 11 2024	SELL Payment of exercise price or tax liability	$44,049 $25.61 p/Share	1,720 Reduced 13.43%	11,086 Common Stock
Mar 11 2024	BUY Exercise of conversion of derivative security	-	5,856 Added 33.1%	11,838 Common Stock
Oct 01 2023	SELL Payment of exercise price or tax liability	$13,637 $18.63 p/Share	732 Reduced 12.66%	5,052 Common Stock
Oct 01 2023	BUY Exercise of conversion of derivative security	-	2,491 Added 30.1%	5,784 Common Stock

Anne Nunes

SVP, Chief Operations Officer

Bedford, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ANIK shares.

Notify only if

Value

Insider Trading

Get notified when an Anika Therapeutics, Inc. insider buys or sells ANIK shares.

Notify only if

Operation

Value

Type

News

Receive news related to Anika Therapeutics, Inc.

Track Activities on ANIK

Account